Cargando…
A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy
Autores principales: | Huang, Tuxiong, Yang, Jiao, Liu, Beilei, Fu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365451/ https://www.ncbi.nlm.nih.gov/pubmed/32510874 http://dx.doi.org/10.1002/cac2.12066 |
Ejemplares similares
-
TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response
por: Zeng, Zexian, et al.
Publicado: (2021) -
Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models
por: Rios-Doria, Jonathan, et al.
Publicado: (2015) -
Machine learning on syngeneic mouse tumor profiles to model clinical immunotherapy response
por: Zeng, Zexian, et al.
Publicado: (2022) -
Roles and therapeutic implications of m6A modification in cancer immunotherapy
por: Pan, Juan, et al.
Publicado: (2023) -
Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models
por: Predina, J D, et al.
Publicado: (2011)